Australia approves Gilead’s remdesivir for COVID-19 treatment

Australia has granted provisional approval to Gilead Sciences's remdesivir as the first treatment option for COVID-19 in the country, the Therapeutic Goods Administration (TGA) said on Friday. Read More

from Canoe https://ift.tt/3gLSrbW